381 related articles for article (PubMed ID: 9818664)
1. Variations in physicians' judgments about corticosteroid induced osteoporosis by physician specialty.
Buckley LM; Marquez M; Hudson JO; Downs RW; Vacek P; Small RE; Poses R
J Rheumatol; 1998 Nov; 25(11):2195-202. PubMed ID: 9818664
[TBL] [Abstract][Full Text] [Related]
2. Prevention of corticosteroid-induced osteoporosis: results of a patient survey.
Buckley LM; Marquez M; Feezor R; Ruffin DM; Benson LL
Arthritis Rheum; 1999 Aug; 42(8):1736-9. PubMed ID: 10446875
[TBL] [Abstract][Full Text] [Related]
3. Physician and patient perceptions on the use of vitamin D and calcium in osteoporosis treatment: a European and Latin American perspective.
Resch H; Walliser J; Phillips S; Wehren LE; Sen SS
Curr Med Res Opin; 2007 Jun; 23(6):1227-37. PubMed ID: 17559732
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup.
Adachi JD; Bensen WG; Bianchi F; Cividino A; Pillersdorf S; Sebaldt RJ; Tugwell P; Gordon M; Steele M; Webber C; Goldsmith CH
J Rheumatol; 1996 Jun; 23(6):995-1000. PubMed ID: 8782129
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroid-induced osteoporosis.
Joseph JC
Am J Hosp Pharm; 1994 Jan; 51(2):188-97; quiz 229-30. PubMed ID: 8160669
[TBL] [Abstract][Full Text] [Related]
6. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
[TBL] [Abstract][Full Text] [Related]
7. Prevention of corticosteroid induced osteoporosis in inpatients recently discharged from a tertiary teaching hospital.
Smith MD; Cheah SP; Taylor K; Ahern MJ
J Rheumatol; 2001 Mar; 28(3):566-70. PubMed ID: 11296960
[TBL] [Abstract][Full Text] [Related]
8. Corticosteroid osteoporosis: practical implications of recent trials.
Sambrook PN
J Bone Miner Res; 2000 Sep; 15(9):1645-9. PubMed ID: 10976984
[TBL] [Abstract][Full Text] [Related]
9. Physician perception of patient adherence compared to patient adherence of osteoporosis medications from pharmacy claims.
Copher R; Buzinec P; Zarotsky V; Kazis L; Iqbal SU; Macarios D
Curr Med Res Opin; 2010 Apr; 26(4):777-85. PubMed ID: 20095797
[TBL] [Abstract][Full Text] [Related]
10. The role of vitamin D in corticosteroid-induced osteoporosis: a meta-analytic approach.
Amin S; LaValley MP; Simms RW; Felson DT
Arthritis Rheum; 1999 Aug; 42(8):1740-51. PubMed ID: 10446876
[TBL] [Abstract][Full Text] [Related]
11. Multifaceted educational program increases prescribing of preventive medication for corticosteroid induced osteoporosis.
Naunton M; Peterson GM; Jones G; Griffin GM; Bleasel MD
J Rheumatol; 2004 Mar; 31(3):550-6. PubMed ID: 14994404
[TBL] [Abstract][Full Text] [Related]
12. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
Brodowska A
Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacological prevention of osteoporosis in patients on corticosteroid medication].
Lems WF; Jacobs JW; Netelenbos JC; Dijkmans BA; Bijlsma JW
Ned Tijdschr Geneeskd; 1998 Aug; 142(34):1904-8. PubMed ID: 9856175
[TBL] [Abstract][Full Text] [Related]
14. Suggested rationale for prevention and treatment of glucocorticoid-induced bone loss in dermatologic patients.
Yosipovitch G; Hoon TS; Leok GC
Arch Dermatol; 2001 Apr; 137(4):477-81. PubMed ID: 11295929
[TBL] [Abstract][Full Text] [Related]
15. Corticosteroid induced osteoporosis. Guidelines for treatment.
Sambrook PN; Diamond T; Ferris L; Fiatarone-Singh M; Flicker L; MacLennan A; Nowson C; O'Neill S; Greville H; ;
Aust Fam Physician; 2001 Aug; 30(8):793-6. PubMed ID: 11681155
[TBL] [Abstract][Full Text] [Related]
16. [Post-steroidal osteoporosis].
Drozdzowska B; Pluskiewicz W
Przegl Lek; 1999; 56(2):157-60. PubMed ID: 10375951
[TBL] [Abstract][Full Text] [Related]
17. Compliance with osteoporosis treatment guidelines in postmenopausal women.
Mountjoy CR; Shrader SP; Ragucci KR
Ann Pharmacother; 2009 Feb; 43(2):242-50. PubMed ID: 19196838
[TBL] [Abstract][Full Text] [Related]
18. A cost effectiveness analysis of calcium and vitamin D supplementation, etidronate, and alendronate in the prevention of vertebral fractures in women treated with glucocorticoids.
Buckley LM; Hillner BE
J Rheumatol; 2003 Jan; 30(1):132-8. PubMed ID: 12508402
[TBL] [Abstract][Full Text] [Related]
19. High-dose corticosteroid exposure and osteoporosis intervention in adults.
Che M; Ettinger B; Nguyen MT; Pressman AR; Johnston J
Ann Allergy Asthma Immunol; 2006 Oct; 97(4):497-501. PubMed ID: 17069105
[TBL] [Abstract][Full Text] [Related]
20. Doctors' beliefs and knowledge on corticosteroid-induced osteoporosis: identifying barriers to improve prevention.
Duyvendak M; Naunton M; van Roon EN; Brouwers JR
J Clin Pharm Ther; 2011 Jun; 36(3):356-66. PubMed ID: 21545615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
